title: [Benzodiazepines in the treatment of anxiety].
abstract: During the last ten years, the treatment of anxiety disorders has changed considerably. Cognitive-behavioural therapies and new chemotherapies have been added to benzodiazepine therapy and psychotherapy which for a long time had been the only treatment of these frequent and invalidating disorders. Recent reports of possible drawbacks in prolonged benzodiazepine therapy provide another reason to reconsider the indications of these drugs now that other drugs are available. Benzodiazepines remain the treatment of choice for recent anxiety states requiring some degree of sedation and rapid relief, but their long-term administration should be reserved to patients who did not respond to other treatments. The authors propose several guidelines for a better prescription of these anxiolytic agents and for more rational indications taking into account the advantages of other available treatments.
authors.affiliation: INSERM U-320, Groupe de Psychopharmacologie clinique, Centre Esquirol, CHU Côte de Nacre, Caen.
authors.forename: J P
authors.initials: JP
authors.lastname: Boulenger
authors.forename: V
authors.initials: V
authors.lastname: Pellet
authors.forename: E
authors.initials: E
authors.lastname: Zarifian
mesh_terms: D001007:Anxiety / Q000188:drug therapy*; D001569:Benzodiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced; D005602:France / Q000453:epidemiology; D006801:Humans; D011596:Psychomotor Disorders / Q000139:chemically induced; D019966:Substance-Related Disorders / Q000188:drug therapy
chemical_list: D001569:Benzodiazepines
vernacular_title: Benzodiazépines dans le traitement de l'anxiété.